| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Bva13g01295 | ATGGGTTGCTGCTTCAGTGCTAGGATCAAAGCAGAGAGTCCTCCGCGTAATGGCTCGACTTCAAATTATGTTAGCAAAGACGAGGATACTTTGAGTGGTTTAAGCAGCAAGGTCTCCCTTACCTCTGTGCCTCAAACTCCACGGACAGAGGGTGAGATCTTGCAGTCTGAAAATTTGAACAGCTTCAGCTTTAATGAGCTTAAAACAGCCACAAGGAACTTCCGGCCAGATAGTGTGGTTGGTGAAGGTGGCTTTGGATCTGTCTTCAAGGGGTGGATCGATGAGCAGACATTGACTGCTGCTAAACCTGGGACTGGAACTGTCATTGCCGCGAAGAGGCTTAATCAAGAAGGCTTCCAGGGACACAATGAATGGTTGGCAGAAATCAATTACCTGGGGCAGCTGCATCATCCCAATCTAGTGAAACTGTTTGGTTACTGCTTAGAGGATGACCACCGGCTATTGGTGTATGAATTTCTGCCAAAGGGTAGCTTGGATAACCATTTATTTAGGAGAGCTTCTTACTTTCAGCCACTTTCTTGGGGTATCCGTATGAAGGTTGCCCTTGATGCTGCTAAGGGTCTTGCATTTCTTCACAGTGATGAAGCTAAAGTGATATATCGAGACTTCAAGACATCTAATATTTTGCTTGATTCGAACTATAATGCAAAACTCTCTGATTTTGGGTTGGCAAAGGATGGACCAGTAGGTGATAAGAGCCATGTCTCTACAAGGGTAATGGGCACCTATGGCTATGCCGCTCCTGAGTACATGGCCACAGGTCACTTGACCAAGAAGAGTGATGTCTACAGCTTCGGTGTTGTACTCCTGGAAATTATGTCTGGCAAGCGTGCCATGGACAAAAACAGACCATCTGGAGAACACAATTTGGTTGAATGGGCCAAGCCATATCTTACCAGCAAACGCAGAATCTTCCAAGTTATGGATGCTCGAATTGAAGGCCAATACTCATTGCGTGCAGCAATGAAAGTAGCTAACCTTGCAATTCAATGCCTTTCTGTAGAACCCAGATTCAGACCAACGATGGAAGAGGTGGTAAGAACATTGGAACAGCTTCAGGATTCCAATGACTCAGGCTCAGTGGGAAGCTCTCGAGATCAAACAGTGAGAAAGAGTCACCATAGCTCGAGCTCACGCTCAAGGTCTAGCTCTGGTGCTAGACCCCATAGAAGAAGTATGAATAATTCTTTAAATGGAGAAGGTACTTCTAATCCAAAGCCATCTGCTTCTCCTCTTGTTACTTG | 1265 | 0.4553 | MGCCFSARIKAESPPRNGSTSNYVSKDEDTLSGLSSKVSLTSVPQTPRTEGEILQSENLNSFSFNELKTATRNFRPDSVVGEGGFGSVFKGWIDEQTLTAAKPGTGTVIAAKRLNQEGFQGHNEWLAEINYLGQLHHPNLVKLFGYCLEDDHRLLVYEFLPKGSLDNHLFRRASYFQPLSWGIRMKVALDAAKGLAFLHSDEAKVIYRDFKTSNILLDSNYNAKLSDFGLAKDGPVGDKSHVSTRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEIMSGKRAMDKNRPSGEHNLVEWAKPYLTSKRRIFQVMDARIEGQYSLRAAMKVANLAIQCLSVEPRFRPTMEEVVRTLEQLQDSNDSGSVGSSRDQTVRKSHHSSSSRSRSSSGARPHRRSMNNSLNGEGTSNPKPSASPLVT | 421 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Bva13g01295 | 421 | MobiDBLite | consensus disorder prediction | 385 | 421 | - | - | |
| Bva13g01295 | 421 | Gene3D | Phosphorylase Kinase; domain 1 | 49 | 159 | - | - | |
| Bva13g01295 | 421 | PANTHER | KINASE 1B | 24 | 390 | - | - | |
| Bva13g01295 | 421 | Gene3D | Transferase(Phosphotransferase) domain 1 | 160 | 384 | - | - | |
| Bva13g01295 | 421 | MobiDBLite | consensus disorder prediction | 357 | 373 | - | - | |
| Bva13g01295 | 421 | PANTHER | OS01G0588500 PROTEIN-RELATED | 24 | 390 | - | - | |
| Bva13g01295 | 421 | CDD | STKc_IRAK | 80 | 359 | - | - | |
| Bva13g01295 | 421 | Pfam | Protein tyrosine and serine/threonine kinase | 78 | 356 | IPR001245 | GO:0004672|GO:0006468 | |
| Bva13g01295 | 421 | MobiDBLite | consensus disorder prediction | 357 | 421 | - | - | |
| Bva13g01295 | 421 | ProSitePatterns | Protein kinases ATP-binding region signature. | 80 | 112 | IPR017441 | GO:0005524 | |
| Bva13g01295 | 421 | ProSiteProfiles | Protein kinase domain profile. | 74 | 359 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Bva13g01295 | 421 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 205 | 217 | IPR008271 | GO:0004672|GO:0006468 | |
| Bva13g01295 | 421 | SUPERFAMILY | Protein kinase-like (PK-like) | 52 | 358 | IPR011009 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Bva13g01295 | Bva-Chr13 | 6628826 | 6632163 | Dispersed/Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Bva13g01295 | 44 | 381 | Glycoside Hydrolase | AT3G07070 | 46.000 | 1.73e-105 | 317 |
| Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
|---|---|---|---|---|---|---|---|
| PK | RLK-Pelle_RLCK-VIIa-2 | Bva13g01295 | PK_Tyr_Ser-Thr | 1.6e-45 | CL0016 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Bva13g01295 | - | - | gmx:100775335 | 648.277 |